Advanced skin melanoma – systemic treatment
نویسندگان
چکیده
In Poland, morbidity and mortality rates for melanoma are constantly increasing. In the case of inoperable disease or distant metastases, prognosis remains poor. For many years, dacarbazine has been the gold standard in systemic treatment. Recently, a significant progress in melanoma therapy has been observed. Introducing targeted therapy or immunotherapy significantly improved treatment outcomes. This review paper presents current knowledge on systemic treatment of advanced melanoma, including treatment availability in Poland.
منابع مشابه
Updates in Therapy for Advanced Melanoma.
Cutaneous melanoma is one of the most aggressive forms of skin cancer, and is correlated with a large proportion of skin cancer-related deaths. Therapy for cutaneous melanoma has advanced greatly through careful identification of therapeutic targets and the development of novel immunotherapeutic approaches. The identification of BRAF as well as other driver mutations, have allowed for a special...
متن کاملSystemic Treatment of Metastatic Conjunctival Melanoma
Conjunctival melanoma (CM) is an exceptionally rare tumor, with a propensity for local and distant recurrence, with the lungs, skin, liver, and brain being the most common sites of metastasis. Recent progress in systemic treatments, with checkpoint inhibitors and targeted therapies blocking BRAF and MEK, has redefined the standard of care of advanced unresectable and metastatic melanoma. Althou...
متن کاملStrategies for combining chemotherapy and biotherapy in melanoma.
Cutaneous malignant melanoma is an increasingly common clinical problem. Estimates indicate that in 1999, a total of 44,200 new cases of melanoma were diagnosed.1 Early primary melanoma is cured in most cases, but once the disease becomes metastatic to distant organs, it is almost always fatal. The treatment of metastatic melanoma remains unsatisfactory, with patient survival dictated primarily...
متن کاملCetuximab in Refractory Skin Cancer Treatment
OBJECTIVES Non-melanoma skin cancer is the most common malignancy in US, with an annual incidence of in excess of 1.5 million cases. In the majority of cases, locoregional treatment is curative and systemic therapy is not indicated. Platinum-based chemotherapy regimens have been used most commonly in refractory cases. The use of cetuximab, a monoclonal antibody targeting epidermal growth factor...
متن کاملPharmacokinetic drug evaluation of talimogene laherparepvec for the treatment of advanced melanoma.
INTRODUCTION Current treatment of advanced melanoma is rapidly changing with the introduction of new and effective therapies including systemic as well as locoregional therapies. An example of one such locoregional therapy is intralesional injection with talimogene laherparepvec (T-VEC). Areas covered: T-VEC has been shown in a number of studies to be an effective treatment for patients with st...
متن کامل